U.S. Physical Therapy, Inc. (USPH)
NYSE: USPH · IEX Real-Time Price · USD
101.56
+0.05 (0.05%)
May 1, 2024, 4:00 PM EDT - Market closed

U.S. Physical Therapy Revenue

In the year 2023, U.S. Physical Therapy had annual revenue of $604.80M with 9.34% growth. Revenue in the quarter ending December 31, 2023 was $154.80M with 9.65% year-over-year growth.

Revenue (ttm)
$604.80M
Revenue Growth
+9.34%
P/S Ratio
2.53
Revenue / Employee
$90,000
Employees
6,720
Market Cap
1.53B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023604.80M51.66M9.34%
Dec 31, 2022553.14M58.12M11.74%
Dec 31, 2021495.02M72.05M17.04%
Dec 31, 2020422.97M-59.00M-12.24%
Dec 31, 2019481.97M28.06M6.18%
Dec 31, 2018453.91M39.86M9.63%
Dec 31, 2017414.05M57.51M16.13%
Dec 31, 2016356.55M25.24M7.62%
Dec 31, 2015331.30M26.23M8.60%
Dec 31, 2014305.07M41.02M15.53%
Dec 31, 2013264.06M14.41M5.77%
Dec 31, 2012249.65M18.13M7.83%
Dec 31, 2011231.52M20.29M9.61%
Dec 31, 2010211.23M9.82M4.88%
Dec 31, 2009201.41M13.72M7.31%
Dec 31, 2008187.69M36.00M23.73%
Dec 31, 2007151.69M16.49M12.20%
Dec 31, 2006135.19M8.94M7.08%
Dec 31, 2005126.26M14.55M13.02%
Dec 31, 2004111.71M6.20M5.87%
Dec 31, 2003105.51M10.86M11.47%
Dec 31, 200294.65M13.71M16.93%
Dec 31, 200180.95M17.73M28.04%
Dec 31, 200063.22M11.85M23.08%
Dec 31, 199951.37M6.53M14.57%
Dec 31, 199844.84M6.03M15.54%
Dec 31, 199738.81M6.60M20.49%
Dec 31, 199632.21M7.28M29.22%
Dec 31, 199524.92M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Addus HomeCare 1.06B
Taro Pharmaceutical Industries 610.83M
UFP Technologies 400.07M
Zai Lab 266.72M
ADMA Biologics 258.22M
Ardelyx 124.46M
Inhibrx 1.80M
Revenue Rankings